COVID-19. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In addition to the treatment protocol, patients receive 7 cc of jujube twice a day, 7 cc each. Intervention 2: Control group: The treatment is done according to the
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: The patient does not suffer from any serious concomitant diseases of the pulmonary, cerebral, and endocrine glands The patient's ability and personal desire to fill out a personal consent form to enter the study The patient has not been intubated
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Existence of any history of allergies to jujube and its products The patient's inability to take oral form There are any conditions in the patient that, according to the doctor's judgment, prevent the continuation of medical intervention. Concomitant use of corticosteroids, immunoglobulin or interferon Patient intubation Nausea and vomiting and oral intolerance Treatment-resistant hypoxemia Loss of consciousness Hemodynamic instability Hypercapnia - Respiratory fatigue Existence of any known side effects of consuming any of the components of jujube product
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms (Coronavirus infection). Timepoint: Before starting the study and daily until discharge. Method of measurement: Laboratory values and radiographic changes or CT scans and questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact???? ?????
Semnan University of Medical Sciences
Outcome results
None listed